Trial Profile
Efficacy and safety of COSMOS regimen (sofosbuvir and simeprevir) in liver transplant recipients (LTR) with invariable recurrent hepatitis C (HCV)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Aug 2015
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 10 Aug 2015 New trial record